VRTX Vertex Pharmaceuticals Incorporated
Healthcare$434.52+0.23%ClosedMarket Cap: $110.28B
As of 2026-05-25
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
 BBH | VanEck Biotech ETF | 67,053 | 8.16% |
 IBBQ | Invesco Nasdaq Biotechnology ETF | 12,181 | 7.71% |
 IBB | iShares Biotechnology ETF | 1,354,033 | 7.71% |
 TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 75,849 | 7.14% |
 LSLT | Pacer Salt Low truBeta US Market ETF | 75,849 | 7.14% |
 SLT | Pacer Salt High truBeta US Market ETF | 75,849 | 7.14% |
 VIRS | 75,849 | 7.14% | |
 VETS | 75,849 | 7.14% | |
 IDNA | iShares Genomics Immunology and Healthcare ETF | 12,063 | 3.70% |
 PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 46,466 | 3.01% |
 TECB | iShares U.S. Tech Breakthrough Multisector ETF | 25,163 | 2.91% |
 VGHCX | 2,142,195 | 2.45% | |
 VGHAX | 2,142,195 | 2.45% | |
 AFTY | Pacer CSOP FTSE China A50 ETF | 37,520 | 2.31% |
 XLV | 1,848,362 | 2.16% | |
 IYH | iShares U.S. Healthcare ETF | 133,196 | 2.09% |
 NHG | 133,196 | 2.09% | |
 VHCIX | 764,047 | 1.87% | |
 VHT | 764,047 | 1.87% | |
 CGUS | Capital Group Core Equity ETF | 357,388 | 1.85% |